stockrow
Friday 6 November 2026
Export EWTX’s income statement to Excel — free account
Edgewise Therapeutics, Inc.
EWTX Healthcare Biotechnology
- EPS
- +2,846.5%
- Free cash flow
- −30.2%
Quarter to September 2026, against a year earlier
44.89
6.02
+15.49%
Follow EWTX
Alert me
Edgewise Therapeutics, Inc. (EWTX) EPS (diluted)
Edgewise Therapeutics, Inc.'s EPS (diluted) for fiscal 2025 was −$1.63, compared with −$1.45 in fiscal 2024. Over the twelve months to 30 September 2026 it was $8.19. Over the past ten years it has ranged from −$23.17 (fiscal 2020) to −$1.14 (fiscal 2021); the current reading is higher than 33% of that period. Edgewise Therapeutics, Inc. ranks 305th of 580 Biotechnology companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$1.63 | — |
| FY2024 | −$1.45 | — |
| FY2023 | −$1.57 | — |
| FY2022 | −$1.27 | — |
| FY2021 | −$1.14 | — |
| FY2020 | −$23.17 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $9.65 | — |
| Jun 2026 | −$0.53 | — |
| Mar 2026 | −$0.46 | — |
| Dec 2025 | −$0.47 | — |
| 23 more quarters | Free account |
Against its own ten years
Low −$23.17
High −$1.14
Ten-year median
−$1.51
Current reading's percentile
33
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| ARQT Arcutis Biotherapeutics, Inc. compare | $0.22 |
| LEGN Legend Biotech Corporation Sponsored ADR compare | −$0.50 |
| IOVA Iovance Biotherapeutics, Inc. compare | −$0.53 |
| ABCL AbCellera Biologics Inc. compare | −$0.54 |
| TNGX Tango Therapeutics, Inc. compare | −$0.85 |
| RLAY Relay Therapeutics, Inc. compare | −$1.57 |
| EWTX Edgewise Therapeutics, Inc. | −$1.85 |
| DFTX Definium Therapeutics, Inc. compare | −$3.43 |
| XENE Xenon Pharmaceuticals Inc. compare | −$4.74 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item